James Edgemond
2016
In 2016, James Edgemond earned a total compensation of $4.1M as Chief Financial Officer and Treasurer at United Therapeutics, a 36% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $1,039,675 |
|---|---|
| Non-Equity Incentive Plan | $360,000 |
| Option Awards | $2,097,315 |
| Salary | $591,014 |
| Other | $21,450 |
| Total | $4,109,454 |
Edgemond received $2.1M in option awards, accounting for 51% of the total pay in 2016.
Edgemond also received $1M of change in pension value and nonqualified deferred compensation earnings, $360K in non-equity incentive plan, $591K in salary and $21.5K in other compensation.
Rankings
In 2016, James Edgemond's compensation ranked 2,139th out of 14,075 executives tracked by ExecPay. In other words, Edgemond earned more than 84.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,139 out of 14,075 | 85th |
Division Manufacturing | 733 out of 5,486 | 87th |
Major group Chemicals And Allied Products | 215 out of 1,900 | 89th |
Industry group Drugs | 156 out of 1,543 | 90th |
Industry Pharmaceutical Preparations | 124 out of 1,173 | 89th |
Source: SEC filing on April 28, 2017.
Edgemond's colleagues
We found five more compensation records of executives who worked with James Edgemond at United Therapeutics in 2016.
2016
Roger Jeffs
United Therapeutics
Chief Executive Officer
2016
Martine Rothblatt
United Therapeutics
Chief Executive Officer
2016
Paul Mahon
United Therapeutics
General Counsel
2016
Michael Benkowitz
United Therapeutics
Chief Operating Officer
2016
David Zaccardelli
United Therapeutics